GlassScriptPhysician profile
Nancy Udah
NPI 1750074100
$3,165.04
in general payments reported to CMS, 2019-2025
15 companies · $624 in 2025
The $624 reported for 2025 was more than what 77% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $236 · 2024: $2,305 · 2025: $624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,895 · Travel and Lodging: $1,176 · Education: $94.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,894.79 |
| Travel and Lodging | $1,175.75 |
| Education | $94.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,903.56 | 2023-2024 | Watchman Flx |
| Medtronic, INC. | $402.16 | 2023-2025 | Symplicity G3, Linq II, Mycarelink |
| Cleerly, INC. | $185.43 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Altathera Pharmaceuticals LLC | $162.62 | 2024 | Sotalol Hydrochloride |
| Pfizer INC. | $112.73 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $111.86 | 2024-2025 | Wainua |
| Kestra Medical Technology Services, INC. | $68.48 | 2025 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $57.35 | 2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $36.36 | 2024 | |
| Lexicon Pharmaceuticals, INC. | $31.80 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $21.15 | 2024 | Arcalyst |
| Amgen INC. | $19.19 | 2024 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.02 | 2023 | Lifevest |
| Irhythm Technologies, INC. | $17.69 | 2024 | Zio Monitor, Zio Xt Patch |
| Kiniksa Pharmaceuticals, LTD. | $16.64 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Udah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.